Free Trial

Envestnet Asset Management Inc. Sells 34,400 Shares of Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

Envestnet Asset Management Inc. trimmed its holdings in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 7.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 433,145 shares of the business services provider's stock after selling 34,400 shares during the period. Envestnet Asset Management Inc. owned approximately 0.85% of Exponent worth $38,593,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Private Trust Co. NA boosted its stake in Exponent by 129.8% during the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock valued at $25,000 after buying an additional 157 shares during the period. Atala Financial Inc purchased a new position in shares of Exponent during the fourth quarter worth about $25,000. Westside Investment Management Inc. bought a new position in shares of Exponent in the third quarter worth approximately $26,000. Tortoise Investment Management LLC raised its stake in Exponent by 76.7% in the fourth quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock valued at $39,000 after purchasing an additional 191 shares in the last quarter. Finally, Trust Co. of Vermont bought a new stake in Exponent during the fourth quarter valued at approximately $45,000. Institutional investors own 92.37% of the company's stock.

Exponent Trading Down 1.7 %

Shares of Exponent stock traded down $1.31 on Thursday, hitting $78.08. 94,650 shares of the company traded hands, compared to its average volume of 241,292. Exponent, Inc. has a 12-month low of $73.83 and a 12-month high of $115.75. The firm's 50-day simple moving average is $82.87 and its 200 day simple moving average is $92.71. The company has a market cap of $3.97 billion, a P/E ratio of 36.86 and a beta of 0.84.

Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same quarter in the previous year, the business posted $0.41 EPS. Analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current year.

Insider Activity at Exponent

In related news, VP Richard Reiss sold 1,736 shares of the business's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the sale, the vice president now owns 1,800 shares of the company's stock, valued at $154,674. The trade was a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 2.10% of the stock is currently owned by company insiders.

Exponent Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Articles

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines